Unravel Oncology Mysteries with Functional Proteomics
IsoPlexis
Uncover single-cell insights with comprehensive, proteomic solutions
Articles by IsoPlexis
Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies
Today's Clinical Lab, IsoPlexis
Join Today's Clinical Lab and David Miklos, MD, PhD, to discuss recent advances in bispecific CAR-T therapy and biomarkers for characterizing CAR-T product quality
Single-Cell Proteomics for Immune Profiling in Cancer
IsoPlexis
Proteomics assays provide insight into cancer disease and treatment response, allowing for potent and durable therapies